Pharmaceutical Sector

.

Mylan says Speculations of an Acquisition by Teva is a Rumour

Mylan says Speculations of an Acquisition by Teva is a Rumour

On Friday, Mylan, the Dutch generic drug making company said that speculation which says that that company may be acquired by Teva Pharmaceutical is just a rumour and it doubts whether the regulators would even approve this kind of a deal. The drug makes said that it decides to remain a stand-alone company.

Orexigen Therapeutics Inc’s Anti-Obesity Drug Contrave, May Benefit Cardiovascular Patients

Orexigen Therapeutics Inc’s Anti-Obesity Drug Contrave, May Benefit Cardiovascul

Orexigen Therapeutics Inc's report which said that Contrave, its anti-obesity drug offers surprising benefits to cardiovascular patients helped the company to gain greater than thirty percent on Tuesday.

However the disclosure by the company based in Miami, made the Food and Drug Administration to ask for a second run on the cardiovascular outcomes trial.

Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd in a Cash Deal of Approximately $10.1 Billion

Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd

Valeant Pharmaceuticals International Inc. will be acquiring Salix Pharmaceuticals Ltd. in a cash deal worth approximately $10.1 billion. This move will allow Valeant to add a range of gastrointestinal drugs to its line of offerings.

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To escape an unwanted takeover from Valeant Pharmaceuticals International, the Botox maker Allergan, in its recent defensive move, is planning to sell itself to another bidder Actavis.

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

The$55 billion merger deal of Chicago-based AbbVie with Shire, its U. K. rival could be the first victim of the new rules set by the Obama Administration to clean-up inversion deals.

Pharmaceutical Industry Jostle for Takeover Deals

Pharmaceutical Industry Jostle for Takeover Deals

The pharmaceutical industry is going through a lot of buzz as a number of companies are engaged in talks for acquisition and making deals. Some of the bigger players are busy trying to out-power their competitors.

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd BSE 3.72 % went up to 6.2 per cent in exchange on Monday, after the pharma major said that its new medication revelation program in hostile to infective exploration and has gotten a real help after two of its medications, WCK 771 and WCK 2349, got the Qualified Infectious Disease Product (QIDP) status from the US FDA.

Ackman and Valeant call for special meeting of Allergan shareholders

Ackman and Valeant call for special meeting of Allergan shareholders

William Ackman, who is an activist investor and Valeant Pharmaceuticals International have called for a special meeting with the shareholders of Allergan Inc over their takeover bid for the company.

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen the major drugstore chain of late faced pressure from the shareholders to shift overseas so as to lessen its tax bill like many other drug companies have done recently. Walgreen was earlier looking forward to become a part of a possible agreement with Alliance Boots GmbH the European drugstore chain.

Novartis Expects major part of Revenue from New Products

Novartis Expects major part of Revenue from New Products

Novartis International AG, a Swiss multinational pharmaceutical company based in Basel, was ranked number one in sales among the world-wide industry in 2013.

On Thursday, Bombay Stock Exchange reported a 2% rise in quarterly sales of the company along with an expected future increase in the revenue of the company with the introduction of their new products.

Latest News

Apigee Becomes the Second Tech Company for Silicon Valley to go Public this Year
Massive Crane Begins its First lift Helping to Build the Tappan Zee Bridge
Shares of Facebook Drop as the Social Networking Company Fails to Match Expectat
First Quarter Profits of Discover Financial Services Drops but Surpasses Analyst
Amgen Inc. Announced First Quarter Earnings that Beat Analysts’ Expectations and
Magnificent, Perfect100-carat Diamond Sells for $22Millon in Sotheby’s Jewelry A
Kraft Revamping Its Iconic Macaroni and Cheese Meal by Removing Synthetic Colour
San Juan Capistrano’s Tiered Rates for Water-Use Thrown Out by Appeals Court
Morgan Stanley Announces Better than Expected First Quarter Profits
Bombardier Aerospace secures contract from Air Niugini
Blue Cross and Blue Shield of Alabama and Alfa Insurance Are Expanding their Par
Diners Club
Syndicate content